242 related articles for article (PubMed ID: 33288765)
1. Quantifying the influence of mutation detection on tumour subclonal reconstruction.
Liu LY; Bhandari V; Salcedo A; Espiritu SMG; Morris QD; Kislinger T; Boutros PC
Nat Commun; 2020 Dec; 11(1):6247. PubMed ID: 33288765
[TBL] [Abstract][Full Text] [Related]
2. Principles of Reconstructing the Subclonal Architecture of Cancers.
Dentro SC; Wedge DC; Van Loo P
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28270531
[TBL] [Abstract][Full Text] [Related]
3. MixClone: a mixture model for inferring tumor subclonal populations.
Li Y; Xie X
BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430
[TBL] [Abstract][Full Text] [Related]
4. Parallel evolution of tumour subclones mimics diversity between tumours.
Martinez P; Birkbak NJ; Gerlinger M; McGranahan N; Burrell RA; Rowan AJ; Joshi T; Fisher R; Larkin J; Szallasi Z; Swanton C
J Pathol; 2013 Aug; 230(4):356-64. PubMed ID: 23716380
[TBL] [Abstract][Full Text] [Related]
5. Reconstructing tumor evolutionary histories and clone trees in polynomial-time with SubMARine.
Sundermann LK; Wintersinger J; Rätsch G; Stoye J; Morris Q
PLoS Comput Biol; 2021 Jan; 17(1):e1008400. PubMed ID: 33465079
[TBL] [Abstract][Full Text] [Related]
6. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
Yu Z; Li A; Wang M
BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
[TBL] [Abstract][Full Text] [Related]
7. A community effort to create standards for evaluating tumor subclonal reconstruction.
Salcedo A; Tarabichi M; Espiritu SMG; Deshwar AG; David M; Wilson NM; Dentro S; Wintersinger JA; Liu LY; Ko M; Sivanandan S; Zhang H; Zhu K; Ou Yang TH; Chilton JM; Buchanan A; Lalansingh CM; P'ng C; Anghel CV; Umar I; Lo B; Zou W; ; Simpson JT; Stuart JM; Anastassiou D; Guan Y; Ewing AD; Ellrott K; Wedge DC; Morris Q; Van Loo P; Boutros PC
Nat Biotechnol; 2020 Jan; 38(1):97-107. PubMed ID: 31919445
[TBL] [Abstract][Full Text] [Related]
8. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
Dentro SC; Leshchiner I; Haase K; Tarabichi M; Wintersinger J; Deshwar AG; Yu K; Rubanova Y; Macintyre G; Demeulemeester J; Vázquez-García I; Kleinheinz K; Livitz DG; Malikic S; Donmez N; Sengupta S; Anur P; Jolly C; Cmero M; Rosebrock D; Schumacher SE; Fan Y; Fittall M; Drews RM; Yao X; Watkins TBK; Lee J; Schlesner M; Zhu H; Adams DJ; McGranahan N; Swanton C; Getz G; Boutros PC; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Martincorena I; Markowetz F; Mustonen V; Yuan K; Gerstung M; Spellman PT; Wang W; Morris QD; Wedge DC; Van Loo P;
Cell; 2021 Apr; 184(8):2239-2254.e39. PubMed ID: 33831375
[TBL] [Abstract][Full Text] [Related]
9. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data.
Ha G; Roth A; Khattra J; Ho J; Yap D; Prentice LM; Melnyk N; McPherson A; Bashashati A; Laks E; Biele J; Ding J; Le A; Rosner J; Shumansky K; Marra MA; Gilks CB; Huntsman DG; McAlpine JN; Aparicio S; Shah SP
Genome Res; 2014 Nov; 24(11):1881-93. PubMed ID: 25060187
[TBL] [Abstract][Full Text] [Related]
10. Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data.
Malikic S; Jahn K; Kuipers J; Sahinalp SC; Beerenwinkel N
Nat Commun; 2019 Jun; 10(1):2750. PubMed ID: 31227714
[TBL] [Abstract][Full Text] [Related]
11. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
12. TargetClone: A multi-sample approach for reconstructing subclonal evolution of tumors.
Nieboer MM; Dorssers LCJ; Straver R; Looijenga LHJ; de Ridder J
PLoS One; 2018; 13(11):e0208002. PubMed ID: 30496231
[TBL] [Abstract][Full Text] [Related]
13. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.
Deshwar AG; Vembu S; Yung CK; Jang GH; Stein L; Morris Q
Genome Biol; 2015 Feb; 16(1):35. PubMed ID: 25786235
[TBL] [Abstract][Full Text] [Related]
14. Clonality Inference from Single Tumor Samples Using Low-Coverage Sequence Data.
Donmez N; Malikic S; Wyatt AW; Gleave ME; Collins CC; Sahinalp SC
J Comput Biol; 2017 Jun; 24(6):515-523. PubMed ID: 28056180
[TBL] [Abstract][Full Text] [Related]
15. Computational validation of clonal and subclonal copy number alterations from bulk tumor sequencing using CNAqc.
Antonello A; Bergamin R; Calonaci N; Househam J; Milite S; Williams MJ; Anselmi F; d'Onofrio A; Sundaram V; Sosinsky A; Cross WCH; Caravagna G
Genome Biol; 2024 Jan; 25(1):38. PubMed ID: 38297376
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral heterogeneity and genetic characteristics of prostate cancer.
Wu B; Lu X; Shen H; Yuan X; Wang X; Yin N; Sun L; Shen P; Hu C; Jiang H; Wang D
Int J Cancer; 2020 Jun; 146(12):3369-3378. PubMed ID: 32159858
[TBL] [Abstract][Full Text] [Related]
17. Quantifying the seed sensitivity of cancer subclonal reconstruction algorithms.
Steinberg PL; Liu LY; Neiman-Golden A; Patel Y; Boutros PC
bioRxiv; 2024 Feb; ():. PubMed ID: 38370678
[TBL] [Abstract][Full Text] [Related]
18. Decomposing the subclonal structure of tumors with two-way mixture models on copy number aberrations.
Tai AS; Peng CH; Peng SC; Hsieh WP
PLoS One; 2018; 13(12):e0206579. PubMed ID: 30540749
[TBL] [Abstract][Full Text] [Related]
19. Inferring clonal evolution of tumors from single nucleotide somatic mutations.
Jiao W; Vembu S; Deshwar AG; Stein L; Morris Q
BMC Bioinformatics; 2014 Feb; 15():35. PubMed ID: 24484323
[TBL] [Abstract][Full Text] [Related]
20. Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer.
Kim TM; Jung SH; Baek IP; Lee SH; Choi YJ; Lee JY; Chung YJ; Lee SH
J Pathol; 2014 Aug; 233(4):425-35. PubMed ID: 24870262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
